نتائج البحث - "Bergamino, Milana A"

العلاقة: https://eprints.soton.ac.uk/473624/1/1_s2.0_S2352396422003875_main.pdfTest; Bergamino, Milana A., López-Knowles, Elena, Morani, Gabriele and Cutress, Ramsey , POETIC investigators (2022) HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer. EBioMedicine, 83, [104205]. (doi:10.1016/j.ebiom.2022.104205 ).

الإتاحة: https://doi.org/10.1016/j.ebiom.2022.104205Test
https://eprints.soton.ac.uk/473624Test/
https://eprints.soton.ac.uk/473624/1/1_s2.0_S2352396422003875_main.pdfTest

View record in BASE

4

دورية أكاديمية

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

المؤلفون: Bergamino, Milana A, López-Knowles, Elena, Morani, Gabriele, Tovey, Holly, Kilburn, Lucy, Schuster, Eugene F, Alataki, Anastasia, Hills, Margaret, Xiao, Hui, Holcombe, Chris, Skene, Anthony, Robertson, John F, Smith, Ian E, Bliss, Judith M, Dowsett, Mitch, Cheang, Maggie CU, Evans, Abigail, Ball, Adrian, Johri, Akhil, Nejim, Ali, Jones, Alison, Corder, Allan, Thorne, Amanda, Anand, Ambika, Chakrabarti, Amitabha, Robinson, Anne, Modi, Anupam, Patel, Ashraf, Kothari, Ashutosh, McFall, Brendan, Mortimer, Caroline, Lee, Caroline, Chan, Charlie, Abson, Charlotte, Holcombe, Christopher, Hinton, Christopher, Hollywood, Ciaran, Murphy, Claire, Crowley, Clare, Harding-Mackean, Claudia, Griffith, Clive, Lewanski, Conrad, Rea, Daniel, Hwang, David, Crawford, Derek, Thekkinkattil, Dinesh, Ferguson, Douglas, Adamson, Douglas, Wheatley, Duncan, Ravichandran, Duraisamy, Babu, Ed, Hyett, Elaine, Ashkanani, Fawzia, Hoar, Fiona, Kenny, Frances, Dyke, Gary, Sparrow, Geoffrey, Gilbert, ., Cunnick, Giles, Algurafi, Hafiz, Sweetland, Helen, Prof, Highes-Davies, Hamed, Hisham, Smith, Ian, Laidlaw, Ian, Khattak, Ilyas, Newby, Jacqueline, Rees-Lee, Jacqueline, Kokan, Jalal, Barrett, Jane, Naik, Jay Dolatrai, Vaidya, Jayant, Forrest, Jennifer, Parmar, Jitendra, Adams, Jocelyn, Fox, John, Roberts, Jonathan, Dawson, Jonathan, Doughty, Julie, Donnelly, Jull, Dunn, Kathleen, Chin, Kian, Horgan, Kieran, Thakur, Kislaya, Barthelmes, Ludger, Wyld, Lynda, Bhattacharyya, Madhumita, Hadaki, Maher, Kishore, Makam, Ornstein, Marcus, Bramley, Maria, Bews-Hair, Maria, Parton, Marina, Sibbering, Mark, Kissin, Mark, Churn, Mark, Hogg, Martin, Quigley, Mary, Hatton, Matthew, Winter, Matthew, Adelekan, Matthew, Shere, Michael, Carr, Michael, Williams, Michael, Absar, Mohammed, Sharif, Muhammad, Kelleher, Muireann, Walji, Nawaz, Williams, Nicholas, Gallegos, Nicholas, Bundred, Nigel, Hatcher, Olivia, Crellin, Perric, Crane, Peter, Donnelly, Peter, Kneeshaw, Peter, Walker, Philip, Sinha, Prakash, Bhaskar, Pudhupalayam, Soulsby, Racheal, Todd, Radha, Vidya, Raghavan, Mehra, Rakesh, Prasad, Ramachandran, Cutress, Ramsay, Sharma, Ravi, Roylance, Rebecca, Goranova, Rebecca, Salman, Reem Ramzi, Bonom, Riccardo, Johnson, Richard, Sutton, Richard, Linforth, Rick, Coleman, Rob, Grieve, Robert, Leonard, Robert, Reichert, Robert, Kennedy, Robert, Agarwal, Roshan, Allerton, Rozenn, Burcombe, Russell, Davis, Ruth, Narayanan, Sankaran, Chandrasekharan, Sankaran, Vesty, Sarah, Seetharam, Seema, Ledwidge, Serena, Iqbal, Shabana, Wahee, Shamaela, Silva, Shobha, Pain, Simon, Holt, Simon, Thomson, Simon, Smith, Simon, Ellenbogen, Simon, Laws, Siobhan, Chan, Stephen, Johnston, Stephen, Holt, Steve, Thrush, Steven, McIntosh, Stuart, Chatterjee, Sumohan, Cleator, Susan, Usman, Tamoor, Johnson, Tayo, Kovacs, Tibor, Irvine, Tracey, Barthkur, Urmila, Pope, Vanessa, Brown, Victoria Alexandra, Muralikrishna, Vummiti, Samra, Walid, Maxwell, William, Winters, Zoe

المصدر: eBioMedicine , Article 104205. (2022) (In press).

مصطلحات موضوعية: Breast cancer, HER2+, Aromatase inhibitors, HER2-Enriched subtype

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10154096/1/1-s2.0-S2352396422003875-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10154096Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10154096/1/1-s2.0-S2352396422003875-main.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10154096Test/

View record in BASE

5

دورية أكاديمية

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study

المؤلفون: Gil-Gil, Miguel J., Bergamino, Milana, Barnadas, Agustí, Manso, Luis, Bellet Ezquerra, Meritxell, Saura Manich, Cristina, Morales, Serafin

المساهمون: Institut Català de la Salut, Gil-Gil MJ, Bergamino M Department of Medical Oncology, Institut Català d’Oncologia, IDIBELL, L’Hospitalet, Spain. Bellet M, Saura C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Morales S Department of Medical Oncology, Hospital Arnau de Vilanova, Lleida, Spain. Barnadas A Department of Medical Oncology, Hospital de Sant Pau, Barcelona, Spain. Manso L Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Mama - Càncer - Quimioteràpia, Avaluació de resultats (Assistència sanitària), Persones grans, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Neoadjuvant Therapy, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::tratamiento neoadyuvante, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión

وصف الملف: application/pdf

العلاقة: Frontiers in Oncology;11; https://doi.org/10.3389/fonc.2021.645026Test; Gil-Gil MJ, Bellet M, Bergamino M, Morales S, Barnadas A, Manso L, et al. Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study. Front Oncol. 2021 Jul;11:645026.; https://hdl.handle.net/11351/6949Test; 000677390600001

الإتاحة: https://doi.org/10.3389/fonc.2021.645026Test
https://hdl.handle.net/11351/6949Test

View record in BASE

النص الكامل